Enhancing Cervical Cancer Screening: New Diagnostic Methodologies, Triage, and Risk Stratification in Prevention and Treatment
Life · 26.02.2025 · 15 (3) · 367
DOI: 10.3390/life15030367 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 26.02.2025. Verfasst von Nazira Kamzayeva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Academic Department of Women's Health, CF "University Medical Center", Astana 010000, Kazakhstan. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
Human papillomavirus (HPV) is a well-established etiological factor in the development of precancerous cervical lesions and cervical cancer. This narrative review synthesizes current evidence on the global prevalence, genotype distribution, and pathophysiological mechanisms of HPV infection, emphasizing regional epidemiological variations that influence prevention and treatment strategies. Particular attention is given to high-risk HPV genotypes, their role in carcinogenesis, and the impact of co-infections and the cervicovaginal microbiota on infection persistence and disease progression. Advances in diagnostic methodologies, including E6/E7 oncoprotein detection, DNA methylation, and microRNA-based assays, are examined in the context of improving screening accuracy and early detection. Furthermore, the review explores the psychological implications of HPV diagnosis and underscores the importance of integrating psychosocial support into clinical management. Given the challenges associated with screening coverage, the potential of self-sampling techniques, particularly in resource-limited settings, is discussed as a means to enhance accessibility and participation in cervical cancer prevention programs. By providing a comprehensive overview of these interrelated factors, this review highlights the necessity of a multidisciplinary approach that integrates novel diagnostic strategies, targeted prevention efforts, and supportive care to mitigate the burden of HPV-associated diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Academic Department of Women's Health, CF "University Medical Center", Astana 010000, Kazakhstan.
- Department of Surgery, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
- Clinical Academic Department of Internal Medicine, University Health Center, CF "University Medical Center", Astana 010000, Kazakhstan.
ORCID-Profile: Nazira Kamzayeva, Gauri Bapayeva, Milan Terzic, Kuralay Kongrtay, Nazira Kadroldinova, Talshyn Ukybassova
Förderung
- Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Kamzayeva, N., Bapayeva, G., Terzic, M., Primbetov, B., Imankulova, B., Kim, Y., Sultanova, A., Kongrtay, K., Kadroldinova, N., & Ukybassova, T. (2025). Enhancing Cervical Cancer Screening: New Diagnostic Methodologies, Triage, and Risk Stratification in Prevention and Treatment. Life, 15(3), 367. https://doi.org/10.3390/life15030367
Vancouver
Kamzayeva N, Bapayeva G, Terzic M, Primbetov B, Imankulova B, Kim Y, et al. Enhancing Cervical Cancer Screening: New Diagnostic Methodologies, Triage, and Risk Stratification in Prevention and Treatment. Life. 2025;15(3):367. doi:10.3390/life15030367
BibTeX
@article{Kamzayeva2025,
author = {Kamzayeva, Nazira and Bapayeva, Gauri and Terzic, Milan and Primbetov, Berik and Imankulova, Balkenzhe and Kim, Yevgeniy and Sultanova, Arailym and Kongrtay, Kuralay and Kadroldinova, Nazira and Ukybassova, Talshyn},
title = {Enhancing Cervical Cancer Screening: New Diagnostic Methodologies, Triage, and Risk Stratification in Prevention and Treatment},
journal = {Life},
year = {2025},
volume = {15},
number = {3},
pages = {367},
doi = {10.3390/life15030367}
}
EUVIMED